With less than a month until the 2026 NFL draft, teams are working on their prospect boards. It's tough for each of them to come to a consensus because there are always a lot of opinions across front ...

Chief of the US Central Command, Adm. Brad Cooper, says the American military has struck over 10,000 targets in Iran since the start of the war, as part of which it destroyed two-thirds of the ...

The Thunder are even more dominant in '25-26 than last season -- when they posted the biggest scoring margin ever. The Associated Press OKLAHOMA CITY (AP) — A look at the defending NBA champion ...

After series of delays, US space agency hopes to carry out first crewed flyby of the moon in more than half a century Nasa has begun returning its towering SLS rocket and Orion spacecraft to its ...

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Kyocera (TSE:6971) has introduced an advanced optoelectronic module that ...

NASA believes its equipment is prepared for an Artemis II launch around April 1. CBS News' Bill Harwood has the latest. Donald Trump faces new impeachment articles after odds hit all-time high Verdict ...

Add Yahoo as a preferred source to see more of our stories on Google. NASA plans to haul its Artemis II moon rocket back out to its seaside launch pad next week to ready the huge booster for blastoff ...

NASA plans to launch four astronauts on a long-awaited trip around the moon as early as April 1, it announced Thursday. Subscribe to read this story ad-free Get unlimited access to ad-free articles ...

Luke Littler says Premier League victory in Cardiff "massive" ahead of successful UK Open defence, insists doubters spur him on; world No 1 praises James Wade as a "gentleman" after victory in ...

Forbes contributors publish independent expert analyses and insights. Pam Danziger reports on retail, focused on the luxury consumer market. This voice experience is generated by AI. Learn more. This ...

The FDA sent 30 notices to companies that were making "false and misleading claims" to sell compounded GLP-1 medications. These products are commonly marketed as cheaper alternatives to branded ...